Company Directory > MedTech > Near Infrared Imaging, Inc.
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Near Infrared Imaging, Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Near Infrared Imaging, Inc. (NII) is a medical technology company specializing in the design and distribution of near-infrared vein illumination systems. Its flagship product, the Vein-Eye Carry, is a portable, non-contact device used to visualize sub-dermal veins for improved vascular access in hospitals, ambulances, and home healthcare settings. The company focuses on providing affordable medical solutions to a global market. It maintains a strategic focus on intellectual property, holding core patents for its hardware platform and proprietary data sets. Recently, the company has entered into partnerships to incorporate AI-driven diagnostics and analytics into its imaging technology to support applications like post-surgical monitoring and biometric authentication.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Diagnostic Imaging
SIZE & FINANCIALS
Employees:51-200
Founded:2013
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:City University of New York (CUNY), Lawrence Livermore National Laboratory (LLNL)
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:Near-Infrared Imaging
Active Trials:0
Trial Phases:-
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Remergify (Strategic corporate transformation and AI integration), Farrington Capital Group (AI development for medical diagnostics)
COMPETITION
Position:Niche Player
Competitors:AccuVein, Teledyne FLIR LLC, Hamamatsu Photonics K.K.
LEADERSHIP
Key Executives:
Mike Feeney - CEO
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Near Infrared Imaging, Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.